Clinical Trial Update: Tumor-induced Osteomalacia Disease Monitoring Program

View source ↗

Summary

This document describes an ongoing disease monitoring program for Tumor-induced Osteomalacia. The study is sponsored by Ultragenyx Pharmaceutical and is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor-induced Osteomalacia

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Tumor-induced Osteomalacia (TIO) | Status: ACTIVE_NOT_RECRUITING